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The objective of this study was to determine the effects of different intramuscular dosages
of human chorionic gonadotropin (hCG) on ovarian follicular development of dairy cows
diagnosed with refractory cystic ovarian follicles (COFs). Cows diagnosed with COFs
(≥25mm in diameter) were allocated to four treatment groups: hCG-1 (n = 3), a single
dose of 4,500 IU on day 1; hCG-2 (n= 3), 2,250 IU on days 1 and 3; hCG-3 (n= 3), 1,500
IU on days 1, 3, and 5; and hCG-C (n = 3) received saline on day 1. Blood sampling and
ovarian ultrasonographic (US) examinations were performed on days 1, 3, 5, 7, and 14.
A progesterone (P4) value < 1 ng/ml was used as an indicator of absence of a functional
CL. A significant increase (P < 0.05) in the number of follicles < 4mm in diameter was
observed in the hCG-2 group on day 5. Additionally, there was a significant difference in
the number of follicles <4mm (P < 0.05) between both the hCG-2 and hCG-3 groups
compared to the hCG-C group on day 5, and a tendency (P = 0.08) toward a difference
in the number of 5–9mm follicles in groups hCG-3, hCG-2, and hCG-1, compared with
the hCG-C group on day 7. The proportion of cows on days 7 and 14 with P4 > 1 ng/ml
was 100% (3/3) and 100% (3/3) in group hCG-1; 100% (3/3) and 67% (2/3) in group
hCG-2; 67% (2/3) and 100% (3/3) in group hCG-3; and 33% (1/3) and 33% (1/3) in group
hCG-C, respectively. Strong tendencies of P4 increases in group hCG-1 (P = 0.054) and
hCG-2 (P = 0.051) were measured after hCG administration. Additionally, P4 values
tended to be higher (P = 0.07) for group hCG-1 compared to group hCG-C on day
5. The preliminary findings of this study suggest that multiple smaller doses of hCG
might be equally effective as a single large dose of hCG in modulating ovarian follicular
development in dairy cows with COFs.
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INTRODUCTION
Cystic ovarian follicles (COFs) are a common cause of
reproductive failure in female cattle (1–4). Traditionally, COFs
were defined as non-ovulatory follicular structures measuring
greater than or equal to 25mm that persist for at least 10 days
without the presence of a functional corpus luteum (CL) (4, 5).
This definition has been modified to include follicular structures
with diameters ranging from 17 to 22mm and persisting for 7
to 8 days (3, 4). Previous reports estimate that the incidence
of COFs in dairy cattle varies between 6 and 60%. They may
spontaneously resolve before the first postpartum ovulation and
thus may go undetected (1, 2). Cystic ovarian follicles are
thought to result from neuro-endocrinological dysfunction of the
hypothalamic-pituitary-gonadal axis (2, 6), often combined with
local dysregulation during follicular development (7). However,
despite extensive research, the mechanism of COF development
is unclear (7–9).
Under field conditions, the diagnosis of COFs is based
on behavioral abnormalities, transrectal examination of the
FIGURE 1 | Experimental protocol of the hCG administrations, blood sampling, and ovarian ultrasonographic examination for each group.
genital tract including ultrasonography (US), and occasionally,
blood progesterone (P4) profiles. Different treatment regimens
involving gonadotropin releasing hormone (GnRH), human
chorionic gonadotropin (hCG), prostaglandin F2α (PGF2α), and
P4 have been used with variable ovarian responses and cure rates
(2, 10, 11). Human chorionic gonadotropin has been used to
successfully treat COFs non-responsive to GnRH (2, 5). However,
due to its high molecular weight and carbohydrate content,
repeated administration of hCGmay result in the development of
hCG antibodies in cattle (12, 13). Regarding this point, Giordano
et al. (13) reported that circulating levels of hCG antibody that
may interfere with ovulation were not reached until 7 to 14
days after the hCG (2,000 IU) injection. These results suggest
that low doses of hCG administered more than once within 7
days may be a practical alternative for the treatment of COFs
in dairy cows. However, to our knowledge, administration of
a single dose of 3,000 to 10,000 IU hCG is routinely used to
treat COFs in cattle, and no field studies have explored the
administration of repeated low doses of hCG in cows with
COFs, especially focusing on ovarian follicular development after
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the hCG administration. Therefore, determining the therapeutic
significance of hCG for COFs that are non-responsive to GnRH
is important. The objective of this preliminary field study was to
explore the effects of different hCG dosages (single vs. multiple




Lactating Holstein cows from five commercial dairy farms
in Yamaguchi Prefecture, Japan, were used for this study.
The study was performed from April 2013 to November
2014. All animals were cared for according to the Guide
for the Care and Use of laboratory Animals (Faculty of
Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan),
and informed consent was obtained from all the dairy farmers.
Cows were housed in free stall barns and fed ad libitum
total mixed ration diet and water. The diet was formulated
to meet the requirements of high-production lactating dairy
cows (NRC recommendations). The body condition scores
of the cows were between 3.25 and 3.5, and the average
yearly herd milk yield was between 8,000 and 9,000 kg.
Throughout the experiments, cows were milked twice daily,
and concurrent systemic or metabolic diseases were monitored.
All cows used in the present study were free of these
diseases.
Diagnosis/Detection of Cows With Cystic
Ovarian Follicles, Treatment, and Blood
Sampling
Cows were selected during routine farm visits based on
the farmers’ complaints and postpartum reproductive records
provided by local veterinarians. Based on preliminary selection
by the veterinarians, postpartum cows with an anovulatory
follicle greater than 25mm in diameter by rectal palpation
and US monitoring that persisted on the ovary for more
than 7 days without a functional CL, were diagnosed with
COFs in accordance with published reports (2–4), by one
veterinarian. Among the cows with COFs, some had been
artificial inseminated more than three times and had not
become pregnant, and had received additional hormonal
treatment (excluding hCG) during the postpartum period. In
this study, plasma P4 concentrations of all stored collected
blood samples were measured following treatment with one
assay. Therefore, the function of the CLs of the cows in each
treatment group was unknown at the time of the first hCG
administration. Based on the P4 concentrations measured after
hCG administration, all the cows with a P4 concentration of
more than 1.0 ng/ml at the commencement of the study were
considered to have a functional CL (14), and excluded from the
study.
Cows diagnosed with COFs were randomly allocated to four
treatment groups; hCG-1 (n = 3; age: 2.3 ± 0.6 years), a single
dose of 4,500 IU on day 1 (first day of treatment); hCG-2 (n = 3;
age: 4.0± 2.6 years), 2,250 IU on days 1 and 3; hCG-3 (n= 3; age:
5.3 ± 2.1 years), 1,500 IU on days 1, 3, and 5; and the control,
hCG-C (n = 3; age: 3.3 ± 1.5 years), a single saline dose (1ml)
on day 1. All injections were intramuscular. Treatment began for
hCG-1 at 149.0 ± 19.9 days in milk (range; 126–161 days); for
hCG-2 at 177.0± 157.2 (range; 67–357 days); for hCG-3 at 221.0
± 124.2 (range; 90–337 days); and hCG-C at 113.3± 75.4 (range;
63–200 days).
Jugular vein blood samples from each group were collected
for serum P4 profiling, on days 1, 3, 5, 7, and 14. Collected blood
samples were immediately placed in an icebox and transported
to the laboratory. After centrifugation at 500 × g for 10min
at room temperature, the serum was separated and frozen at
−30◦C until hormone analysis. Transrectal US scanning of
both ovaries was also conducted on days 1, 3, 5, 7, and 14
using a linear array US scanner equipped with a 5-MHz rectal
probe for evaluating follicular dynamics. At each sampling
point, ovarian structures were evaluated by US scanning and
video recorded; both the number and size of visible antral
follicles and CLs weremeasured. The study procedures, including
hCG administration, blood sampling, and US monitoring, are
illustrated in Figure 1.
P4 Assay
Plasma P4 concentrations were determined by an enzyme
immunoassay after extraction with a diethyl ether, as previously
described (15). The extraction efficiency of P4 was 90%. The 50%
effective dose of the P4 assay was 0.66 ng/ml, and the minimum
detectable concentration of this assay was 0.05 ng/ml. The mean
intra-assay and inter-assay coefficients of variation were 2.9 and
TABLE 1 | Summary of the ovarian activities of four groups during the
experimental periods.
hCG treatment group hCG-1 hCG-2 hCG-3 hCG-C
Number of Cows 3 3 3 3
Age, years 2.3 ± 0.6 4.0 ± 2.6 5.3 ± 2.1 3.3 ± 1.5
Cystic ovarian follicle
(≥25mm)
Area increased 0 1 0 0
Area reduced 3 2 3 3
Luteinized 1 0 0 0
Ovulation 0 0 1 0
Appearance of
new CL
Number 3 3 3 1
Appearance of
new CL
Day 3 1 1 0 0
Day 5 1 0 1 0
Day 7 1 2 2 0
Day 14 0 0 0 1
Appearance of new
cystic ovarian follicle
Day 14 0 0 1 1
Cows diagnosed with cystic ovarian follicles were allocated into four treatment groups;
hCG-1, a single dose of 4,500 IU on day 1; hCG-2, 2,250 IU on days 1 and 3; hCG-3,
1,500 IU on days 1, 3, and 5; and control, hCG-C received saline on day 1.
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1.9%, respectively. Hormonal data were used to confirm and
support the US monitoring of CL and follicular development.
Clinical Data Analysis
After hCG administrations, the occurrence of ovulation was
detected by US monitoring, and CL formation was confirmed
through plasma P4 concentrations higher than 1 ng/ml in
three consecutive samples. The number of follicles was
counted and categorized as follows: less than 4, 5–9, 10–14,
and 15–19mm.
Statistical Analysis
All statistical analyses were carried out using StatView R©
computer software (Abac Concept, Inc., Berkeley, CA,
USA). The area of COF, number of follicles, and P4
concentrations were expressed as means ± SEM. A non-
parametric analysis of variance (Kruskal-Wallis) was used
to explore the between-group (treatment) differences in
follicular number and the P4 concentrations, and the within-
group (each day after hCG administration) differences in P4
concentrations. Probability values less than 0.05 (P < 0.05)
were considered statistically significant, while P-value less
than 0.1 (P < 0.1) were considered to indicate a trend toward
significance.
RESULTS
Ovarian Activity After hCG Administrations
Detected by US
Table 1 provides a summary of ovarian activity of the four
treatment groups during the 14-day experimental period. With
the exception of one cow in the hCG-2 group, all animals
with COFs exhibited size reductions, luteinization, or ovulation
after hCG administration. After hCG administration, new CL
development was observed in 3, 3, 3, and 1 cow(s) out of 3
cows each in the hCG-1, hCG-2, hCG-3, and hCG-C groups,
respectively. On day 14, new COFs were not observed in group
hCG-1 or group hCG-2, but one was identified in a cow in
group hCG-3.
Figure 2 shows the mean number of follicles classified by
diameter. A significant increase in the number of follicles< 4mm
in diameter (P < 0.05) was observed in group hCG-2 on day 5
compared to the other days. Additionally, a significant difference
in the number of follicle< 4mm (P < 0.05) between both groups
hCG-2 and hCG-3, compared with group hCG-C, was observed
at day 5. A tendency (P = 0.08) for the number of follicles 5–
9mm to increase in groups hCG-3, hCG-2, and hCG-1 compared
with group hCG-C on day 7 was observed. No differences were
observed between groups for number of follicles that were 10–14














































































































FIGURE 2 | Mean number of developed follicles, categorized by diameter, in each group. *Indicates that the number of follicles on day 5 in the hCG-2 group was
significantly different than other days within the group; a,b, significantly different (P < 0.05); c,d, tendency for a difference (P < 0.1).
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FIGURE 3 | Mean (± SEM) change in the area of cystic ovarian follicles in
cows in each group. The area of the cystic follicle on day 1 was considered
100%. *Indicates significant reduction in cystic ovarian follicle area compared
with day 1.
Figure 3 shows the change in COF area after the hCG
administration in each group, compared to the original COFs
area. Although the size of all COFs from all groups decreased,
the only significant reduction in area was observed in the hCG-C
group.
Progesterone Concentration After hCG
Administration
Figure 4 shows the blood P4 profiles of each group after hCG
administrations. A tendency for the P4 concentration to increase
(P < 0.1) was observed in groups hCG-1 and hCG-2 on day 14
compared with day 1. Progesterone levels in all the hCG groups
on day 14 were greater than 1 ng/ml, suggesting the development
of a functional CL. The proportion of cows on day 7 and 14
with P4 > 1 ng/ml was 100% (3/3) and 100% (3/3) in hCG-1;
100% (3/3) and 67% (2/3) in hCG-2; 67% (2/3) and 100% (3/3)
in hCG-3; and 33% (1/3) and 33% (1/3) in hCG-C, respectively.
Additionally, a tendency for a difference in the P4 concentration
(P = 0.07) was observed between groups hCG-1 and hCG-C on
day 5.
DISCUSSION
In the present study, we focused on the effectiveness of alternative
methods of administration of hCG, i.e., single or multiple divided
doses for cows diagnosed with refractory COFs, to assess ovarian
responses and serum P4 concentrations. Although the number
of cows included in the study was small, our results suggest that
repeated low doses of hCG over time may enhance the ovarian
follicular development of the cows with COFs.
Different responses of COFs to hCG treatment have been
reported, including partial or complete luteinization, regression,
and ovulation (1, 2). In the present study, a significant regression
of the refractory COFs was observed in the hCG-3 group
on day 7 compared to the other groups, indicating that the
repeated administration of low dose hCG may be more effective



































FIGURE 4 | Serum P4 concentration (mean ± SEM) of each hCG group. a,b,
a tendency (P = 0.07) for a difference between the hCG-1 and hCG-C groups
was observed. *A tendency for an increase in P4 concentrations was
observed in the hCG-1 (P = 0.054) and hCG-2 (P = 0.051) groups at day 14
compared with day 1.
the development and selection of new dominant follicles 4
days after treatment (11). The number of follicles < 4mm
in diameter increased after administration of hCG in groups
hCG-2 and hCG-3. This may be the result of the low dose
and successive administration of hCG. The follicles may have
increased in size to 5–9mm in diameter by day 5 or day
7; however, our observation that the number of larger sized
follicles (possibly dominant follicles; 5–9 and 10–14mm in
diameter) decreased on day 3, may be due to ovulation after
the luteinizing hormone (LH) surge, associated with hCG
administration, resulting in the development of new, small
follicles by day 5. Overall, our results indicate that various
hCG administration methods do not significantly affect ovarian
follicular development but may affect the size and category of
follicular numbers.
One advantage of using hCG instead of GnRH to induce
ovulation is that the actions of hCG are not affected by in vivo
P4 levels. Conversely, the ovulatory response to GnRH may
vary significantly, depending on the endocrine milieu at the
time of injection, because the magnitude of the LH surge is
dependent upon the circulating concentrations of P4 (13). Our
results suggest that the hCG administration method (dose and/or
pattern) in cows with COFs may affect the ovarian response,
and thus the therapeutic efficacy. Recently, a treatment protocol,
based on the sequential administration of GnRH, PGF2α, and
GnRH (GPG protocol), was developed as a therapeutic strategy
for ovarian cysts (16, 17). Our results regarding follicular
development of cows with COF suggest that repeated, low-
dose hCG administration, instead of one single GnRH injection,
may be a practical alternative treatment for COFs, especially
considering that repeated low-dose hCG administration was
associated with the recruitment of a significantly larger number
of follicles < 4 and 5–9mm in diameter.
In conclusion, our results suggest that low dose and
repeated administration of hCG may be an effective alternative
therapy for cows with refractory COFs. Ovarian follicular
recruitment and further development were affected by the
Frontiers in Veterinary Science | www.frontiersin.org 5 June 2018 | Volume 5 | Article 130
Ono et al. Cystic Ovarian Follicles in Cattle
different hCG dosages in the study. However, ovulatory response
and CL formation were not different among the various
hCG treated groups. Further research under field conditions
and involving a large number of cows and measurement
of anti-hCG antibodies after hCG administration, are
warranted.
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